GROSSMAN D KEITH — SEC insider filings
SEC reporting owner CIK 1218702. 58 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers the 50 most recent of 58 filings on record, filed 2021-05-05 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 10,200 shares, $938,978 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 18 legs across 10 filings — 57,557 shares, $1,167,237 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: purchase of 7,000 shares @ $105.07 ($735,490) in NEVRO CORP, filed 2021-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | Director | 17 | — | 18 legs · 57,557 sh · $1,167,237 | 33 |
| NEVRO CORP (NVRO) | Director | 31 | 2 legs · 10,200 sh · $938,978 | — | 34 |
| MiniMed Group, Inc. (MMED) | Director | 2 | — | — | 2 |
Insider filings — GROSSMAN D KEITH
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | MiniMed Group, Inc. (MMED) | Grant/award (A): 11,795 @ $0 | EDGAR |
| 2026-06-05 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-03-11 | 4 | MiniMed Group, Inc. (MMED) | Grant/award (A): 13,889 @ $0 | EDGAR |
| 2025-06-04 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-04-03 | 4 | NEVRO CORP (NVRO) | Disposition to issuer (D): 228,552 | EDGAR |
| 2025-03-11 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,641 @ $5.78 | EDGAR |
| 2025-03-11 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 187,500 · Grant/award (A): 750 (derivative) @ $200 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 4,750 @ $0 · Tax withholding (F): 1,071 @ $5.72 · Tax withholding (F): 1,017 @ $5.72 | EDGAR |
| 2024-12-04 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 928 @ $4.26 | EDGAR |
| 2024-09-05 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,020 @ $5.55 | EDGAR |
| 2024-06-05 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,134 @ $9.33 | EDGAR |
| 2024-06-03 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 31,186 @ $1.11 · Sale (S): 26,230 @ $3.80 · Option exercise (M): 38,117 @ $1.11 · Sale (S): 11,887 @ $3.74 · Option exercise (M): 31,186 (derivative) @ $0 · Option exercise (M): 38,117 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2024-05-28 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 19,169 @ $0 | EDGAR |
| 2024-04-15 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 3,986 @ $13.12 | EDGAR |
| 2024-03-13 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 2,184 @ $14.99 | EDGAR |
| 2024-03-06 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 4,750 @ $0 · Tax withholding (F): 1,597 @ $14.51 | EDGAR |
| 2024-03-05 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,403 @ $14.22 | EDGAR |
| 2023-12-05 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 2,056 @ $18.82 | EDGAR |
| 2023-10-26 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 6,012 @ $15.75 | EDGAR |
| 2023-09-06 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 2,193 @ $20.39 | EDGAR |
| 2023-07-26 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 6,013 @ $24.16 | EDGAR |
| 2023-06-06 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 2,193 @ $28.27 | EDGAR |
| 2023-05-31 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 7,681 @ $0 | EDGAR |
| 2023-04-26 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 22,841 @ $0 | EDGAR |
| 2023-04-13 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 4,263 @ $35.66 | EDGAR |
| 2023-03-14 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 2,757 @ $30.19 | EDGAR |
| 2023-03-07 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 8,798 @ $34.43 | EDGAR |
| 2022-06-01 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 6,880 @ $0 | EDGAR |
| 2022-04-12 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 4,263 @ $0 | EDGAR |
| 2022-03-28 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 147,644 @ $0 · Tax withholding (F): 77,734 @ $67.08 | EDGAR |
| 2022-03-21 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 4,875 @ $70.61 | EDGAR |
| 2022-03-15 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 2,754 @ $64.09 | EDGAR |
| 2022-03-08 | 4/A | NEVRO CORP (NVRO) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2022-03-08 | 4 | NEVRO CORP (NVRO) | Purchase (P): 3,200 @ $63.59 | EDGAR |
| 2022-03-07 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 4,874 @ $85.81 | EDGAR |
| 2021-12-02 | 4 | Outset Medical, Inc. (OM) | Sale (S): 1,296 @ $47.92 | EDGAR |
| 2021-11-02 | 4 | Outset Medical, Inc. (OM) | Sale (S): 2,592 @ $55 · Sale (S): 1,296 @ $54.31 | EDGAR |
| 2021-10-04 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $55 · Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $55 · Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $55 · +6 more | EDGAR |
| 2021-10-04 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 62 @ $1.11 · Sale (S): 62 @ $49.69 · Sale (S): 1,234 @ $49.69 · Option exercise (M): 62 (derivative) @ $0 | EDGAR |
| 2021-09-21 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 4,874 @ $126.63 | EDGAR |
| 2021-09-01 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $49.17 · Option exercise (M): 1,296 (derivative) @ $0 | EDGAR |
| 2021-08-27 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $45 · Option exercise (M): 1,296 (derivative) @ $0 | EDGAR |
| 2021-08-17 | 4 | NEVRO CORP (NVRO) | Purchase (P): 7,000 @ $105.07 | EDGAR |
| 2021-07-02 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $49.23 · Option exercise (M): 1,296 (derivative) @ $0 | EDGAR |
| 2021-06-22 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 4,874 @ $160.45 | EDGAR |
| 2021-06-04 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 3,288 @ $0 | EDGAR |
| 2021-06-02 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 1,296 @ $1.11 · Sale (S): 1,296 @ $47.92 · Option exercise (M): 1,296 (derivative) @ $0 | EDGAR |
| 2021-05-05 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 2,592 @ $1.11 · Sale (S): 2,274 @ $57.87 · Sale (S): 100 @ $58.50 · Sale (S): 218 @ $59.79 · Option exercise (M): 2,592 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1218702 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs